Statin and the Risk of Renal-Related Serious Adverse Events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and Other Placebo-Controlled Trials-Reference-Cited by-同舟云学术

Statin and the Risk of Renal-Related Serious Adverse Events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and Other Placebo-Controlled Trials

Published:2014-06 Issue:12 Volume:113 Page:2018-2020
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Bangalore Sripal,Fayyad Rana,Hovingh G. Kees,Laskey Rachel,Vogt Liffert,DeMicco David A.,Waters David D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases;Dormuth;BMJ,2013

2. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;Circulation,2013

3. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis;Wanner;N Engl J Med,2005

4. High-dose atorvastatin after stroke or transient ischemic attack;Amarenco;N Engl J Med,2006

5. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN);Knopp;Diabetes Care,2006

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pharmacovigilance study of chronic kidney disease in diabetes mellitus patients with statin treatment by using the US Food and Drug Administration adverse event reporting system;Frontiers in Pharmacology;2024-06-21

2. Statin initiation and risk of incident kidney disease in patients with diabetes;Canadian Medical Association Journal;2023-05-28

3. Short-Term Effect of Nutraceutical Fruit Juices on Lipid Metabolism in Patients with Acquired Hypercholesterolemia;International Journal of Molecular Sciences;2023-04-16

4. Kidney and lipids: novel potential therapeutic targets for dyslipidemia in kidney disease?;Expert Opinion on Therapeutic Targets;2022-11-02

5. Statin use before and after the KDIGO Lipids in chronic kidney disease guideline: A population‐based interrupted time series analysis;Basic & Clinical Pharmacology & Toxicology;2022-07-16